Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proteomic Research Services (PRS) was a specialized contract research organization (CRO) based in Ann Arbor, Michigan, that provided advanced proteomics and protein characterization services to the pharmaceutical and biotechnology industries. Spun off from Genomic Solutions in 2001, the company focused on protein identification, differential expression analysis, and proteome mapping using high-resolution mass spectrometry and 2D-PAGE technologies. PRS played a significant role in biomarker discovery and drug development projects, offering expertise in complex biological sample analysis. In 2006, the company was acquired by NextGen Group PLC for approximately $1.7 million and integrated into its NextGen Sciences division to expand its proteomics service footprint in North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proteomic Research Services.